QingSong Health Corporation announced that its Board resolved on 30 April 2026 to seek shareholder approval for a new 2026 Share Incentive Scheme at the upcoming AGM scheduled for 22 May 2026 in Beijing.

Key terms of the proposed scheme • Scheme limit: Up to 10% of the Company’s issued share capital on the approval date; a sub-limit of 1% is set for service providers. • Share source: Treasury shares and existing shares repurchased on- or off-market. • Effectiveness: Conditional on (1) shareholder approval and (2) the Stock Exchange Listing Committee’s approval for the listing and dealing in shares to be issued under the plan.

Existing incentives in place The Company’s pre-IPO share option plan, originally adopted in 2015 and restated in 2017, remains in force for outstanding grants. As at the announcement date, 82 participants hold options over 28.09 million shares, representing 13.61% of issued share capital. No other share-based schemes are outstanding.

Next steps A circular detailing the 2026 Share Incentive Scheme will be dispatched to shareholders in accordance with Listing Rules requirements. The Company cautioned investors to exercise due care when trading its securities pending formal approval.